Idarubicin Hydrochloride Injection, Solution
Product Images NDC 0143-9218

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Idarubicin Hydrochloride (NDC 0143-9218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Idarubicin Hydrochloride Injection Usp 1)

Chemical structure of Idarubicin Hydrochloride showing its molecular arrangement with detailed bonds and chemical groups. This image represents the active ingredient Idarubicin Hydrochloride used in intravenous injection solutions by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Idarubicin Hydrochloride Injection, Usp 5 mg/5ml Vial Label (Idarubicin Hydrochloride Injection Usp 2)

Idarubicin Hydrochloride Injection, USP 5 mg/5 mL (1 mg/mL) solution for intravenous use. The label shows the product name, strength, dosage form, and use instructions, including storage conditions and warnings. Labeler is Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Idarubicin Hydrochloride Injection, Usp 10 mg/10 mL Vial Label (Idarubicin Hydrochloride Injection Usp 3)

Idarubicin Hydrochloride Injection, USP 10 mg/10 mL (1 mg/mL) sterile, isotonic solution label for intravenous use only. The single-dose vial label includes usage and storage instructions, a 10 mg/10 mL strength indication, and is manufactured by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Idarubicin Hydrochloride Injection, Usp 20 mg/20 mL Vial Label (Idarubicin Hydrochloride Injection Usp 4)

Idarubicin Hydrochloride Injection, USP 20 mg/20 mL (1 mg/mL) sterile isotonic solution for intravenous use, in a 20 mL single dose vial. The label states storage instructions, warning about severe cellullitis and vesication, and manufacturer information from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp 5)

Label featuring a 2D barcode and printed text fields for lot number, expiration date in month/year format, GTIN, and serial number. This label is associated with Idarubicin Hydrochloride 1 mg/mL injection, solution from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Representative Carton Serialization Image (Idarubicin Hydrochloride Injection Usp 6)

A label including a QR code and human-readable text fields for GTIN, serial number, expiration date, and lot number. The GTIN, serial number, and lot number are shown as alphanumeric codes; the expiration date is indicated by placeholder text 'MMYYYY.' This label is from Idarubicin Hydrochloride Injection, 1 mg/mL by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.